Tasimelteon
DRUG CLASS
- Selective melatonin (MT) receptor agonist
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: August 6, 2020
Citation
Dionesotes, Karen, and E. Alexandra Barany. "Tasimelteon." Johns Hopkins Psychiatry Guide, 2020. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787348/all/Tasimelteon.
Dionesotes K, Barany E. Tasimelteon. Johns Hopkins Psychiatry Guide. 2020. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787348/all/Tasimelteon. Accessed June 1, 2023.
Dionesotes, K., & Barany, E. (2020). Tasimelteon. In Johns Hopkins Psychiatry Guide https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787348/all/Tasimelteon
Dionesotes K, Barany E. Tasimelteon [Internet]. In: Johns Hopkins Psychiatry Guide. ; 2020. [cited 2023 June 01]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787348/all/Tasimelteon.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Tasimelteon
ID - 787348
A1 - Dionesotes,Karen,M.D., M.P.H.
AU - Barany,E. Alexandra,Pharm.D.
Y1 - 2020/08/06/
BT - Johns Hopkins Psychiatry Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787348/all/Tasimelteon
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -